AI Summary
MRK (MRK) is currently trading at $122.03, up 1.06% in the last 24 hours. We maintain a HOLD rating pending clearer directional signals.
Price
Volume
P/E Ratio
Insider
Price Chart
Price Data
Fundamentals
Technical Analysis Summary
27 indicators analyzed
Technical signals are mixed with 15 bullish and 6 bearish indicators. Wait for clearer direction before taking new positions.
Technical Indicators
Momentum & trend signals
💡 Technical indicators are tools, not guarantees. Always combine with fundamental analysis.
MACD
(12, 26, 9)Bollinger Bands
Volatility & breakout detection
Stochastic Oscillator
Momentum indicator (14,3,3)
📊 Neutral: MRK stochastic is in the middle range (96.9). Wait for %K to enter overbought (80+) or oversold (20-) zones for clearer signals.
Average True Range (ATR)
📊 Volatility increasing - consider wider stops to avoid getting stopped out.
On-Balance Volume (OBV)
Volume-based momentum indicator
📈 Volume confirms uptrend: OBV rising above its average suggests institutional accumulation. Bullish signal for trend continuation.
Pivot Points
Key Support & Resistance Levels
All Pivot Levels
Price is trading above the pivot point at $120.16, indicating bullish bias. Watch R1 ($122.02) as the next target.
⚠️ Wide range - higher volatility expected. Use wider stops.
Fibonacci Retracement
| Level | Price | Type | Distance |
|---|---|---|---|
| 0% | $122.66 | Current | -0.4% |
| 23.6% | $111.01 | Support | +9.1% |
| 38.2% | $103.81 | Support | +15.0% |
| 50%✦ | $97.99 | Support | +19.8% |
| 61.8%✦ | $92.16 | Support | +24.6% |
| 78.6% | $83.87 | Support | +31.3% |
| 100% | $73.31 | Support | +40.0% |
VWAP (Volume Weighted Avg Price)
Parabolic SAR
Stop and Reverse Indicator
📈 Uptrend intact (5 days). SAR support at $109.63. Trail stops below SAR.
Williams %R
📈 OVERBOUGHT: Williams %R at -3.1 indicates the stock is trading near its 14-day high. Strong momentum continues - may stay overbought in uptrends.
📊 CCI (Commodity Channel Index)
Momentum oscillator measuring price deviation
Strength: 85%
Previous CCI
+260.6
Typical Price
$121.75
SMA (20)
$111.22
Mean Deviation
$3.19
🔥 EXTREME OVERBOUGHT: CCI at 220.2 (above +200) - extraordinary bullish momentum! CAUTION: CCI starting to decline - potential reversal imminent.
20-Day CCI History
🎯Aroon Indicator(25-period)
📈 STRONG UPTREND: Aroon Up at 100 (above 70) with Aroon Down at 4 (below 30). Price made its 25-day high 0 day(s) ago. Trend is healthy - stay long and trail stops. Oscillator at 96.0 shows bullish bias.
📊 Rate of Change (ROC)Buy
BullishUltimate Oscillator
Multi-timeframe momentum (7, 14, 28)
Keltner Channels
ATR-based volatility bands
📈 EXTENDED ABOVE CHANNEL: Price 122.14 is riding above the upper band (118.54). Strong trend - price can stay extended. Consider trailing stops rather than fading.
TTM Squeeze
John Carter's Volatility Breakout
⚠️ NO SQUEEZE - MOMENTUM WEAKENING: No squeeze currently. Momentum is positive but falling (3.01) - bullish move may be exhausting. Watch for potential reversal or consolidation.
Elder Ray (Bull/Bear Power)
Dr. Alexander Elder's Power Index
🔔 Bearish Divergence detected! Bull Power falling while price makes new highs - potential reversal signal.
Force Index
Dr. Alexander Elder's Volume-Price Momentum
📉 Bearish Divergence detected! Price making higher highs but Force Index making lower highs - buying pressure weakening.
Williams Alligator
Trend Direction & Strength
🍽️ Alligator is EATING - strong bullish trend in progress! Lines properly ordered (Lips 110.35 > Teeth 108.32 > Jaw 107.00). Spread at 3.13%. Ride the trend with trailing stops!
Donchian Channels
Richard Donchian's Breakout System (20-period)
📈 Price at $122.14 is near the 20-day HIGH of $122.66. NEW HIGH TODAY! In an strong uptrend, this confirms strength. In sideways markets, watch for resistance.
Supertrend
ATR-Based Trend Following
📈 UPTREND active for 21 days. Price $122.14 is 18.0% above Supertrend $103.52. Strong trend strength. The Supertrend line serves as trailing support - consider taking partial profits.
Choppiness Index
Trend vs Range Detection (14-period)
📈 TRENDING MARKET (CHOP: 36.5). The market is in a clear trend with low choppiness. Choppiness is stable. Trading advice: Use TREND FOLLOWING strategies (moving average crossovers, breakouts, momentum). Avoid mean reversion or ranging strategies.
Valuation Metrics
Relative value indicators
💡 PEG < 1 suggests undervalued relative to growth • EV/EBITDA accounts for debt
Historical Returns
Price performance across timeframes
📈 Insight: Strong recent momentum with positive year-to-date performance. Consider trailing stop to protect gains.
Seasonality Analysis
Market Comparison
Performance vs S&P 500
Dividend History
Past payments & growth
| Ex-Date | Amount |
|---|---|
| Dec 15, 2025Latest | $0.8500 |
| Sep 15, 2025 | $0.8100 |
| Jun 16, 2025 | $0.8100 |
| Mar 17, 2025 | $0.8100 |
| Dec 16, 2024 | $0.8100 |
| Sep 16, 2024 | $0.7700 |
| Jun 17, 2024 | $0.7700 |
| Mar 14, 2024 | $0.7700 |
Growth Metrics
Year-over-year performance
Growth rates calculated from trailing twelve months vs prior period
Analyst EPS Estimates
Consensus earnings projections
| Fiscal Year | Est. EPS | YoY Growth |
|---|---|---|
| FY26 | $5.15 | -32.4% |
| FY27 | $10.03 | +94.8% |
| FY28 | $11.44 | +14.1% |
Based on analyst consensus estimates. Actual results may vary.
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
Recent News
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider
Merck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
Chromatography Research Report 2026 - Global $13.69 Bn Market Trends, Opportunities, and Forecasts to 2031
FDA Accepts Summit's Lung Cancer Drug Application, Review Underway
2 Pharmaceutical Stocks Set to Rebound in 2026
Why Revolution Medicines Stock Plummeted by Almost 17% Today
Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday?
💪 Strengths
- ✓Healthy profit margins (29.6%)
🚀 Opportunities
- →Market conditions could present buying opportunities
⚠️ Weaknesses
- !No significant weaknesses identified
🛑 Threats
- ✕Broader market volatility remains a risk
⚡ Catalysts
- ★Earnings releases and guidance updates
⚠️ Key Risks
- !Standard market and sector risks apply
Are you an AI agent?
Help improve this research! Submit corrections, updates, or suggestions via Moltbook.
AI Agent Feedback
Are you an AI agent? Help improve this analysis!